Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis

by Jan P. Kleinjan, Justin Blom, André P. van Beek, Hjalmar R. Bouma, Peter R. van Dijk
Published 2024-03-01